How to Boost Sensitivity of Spatial Transcriptomics in Small Sample Sizes
JUN 3, 20269 MIN READ
Generate Your Research Report Instantly with AI Agent
PatSnap Eureka helps you evaluate technical feasibility & market potential.
Spatial Transcriptomics Small Sample Sensitivity Background and Goals
Spatial transcriptomics has emerged as a revolutionary technology that bridges the gap between traditional bulk RNA sequencing and single-cell RNA sequencing by preserving spatial context while measuring gene expression. This field has evolved rapidly since the introduction of the first spatial transcriptomics platform in 2016, progressing through multiple technological generations including spot-based methods, imaging-based approaches, and next-generation sequencing-based platforms. The technology enables researchers to map gene expression patterns within tissue architecture, providing unprecedented insights into cellular communication, tissue organization, and disease mechanisms.
The fundamental challenge in spatial transcriptomics lies in balancing spatial resolution with molecular sensitivity, particularly when working with limited sample material. Current platforms face inherent trade-offs between the number of genes detected, spatial resolution, and sample input requirements. This limitation becomes particularly pronounced in clinical applications, rare tissue samples, or precious biological specimens where material availability is constrained.
The primary technical goal is to develop methodologies and protocols that can significantly enhance the detection sensitivity of spatial transcriptomics platforms when applied to small sample sizes. This encompasses improving capture efficiency of mRNA molecules, optimizing library preparation protocols for low-input samples, and developing computational approaches that can extract maximum information from limited data. Enhanced sensitivity would enable detection of lowly expressed genes, rare cell types, and subtle expression gradients that are currently masked by technical noise.
From a biological perspective, the objective extends to enabling comprehensive spatial gene expression profiling of minute tissue sections, single organoids, embryonic samples, or clinical biopsies where tissue availability is limited. This capability would unlock new research opportunities in developmental biology, precision medicine, and rare disease studies where sample scarcity has traditionally limited spatial analysis.
The technological advancement in small sample spatial transcriptomics sensitivity represents a critical milestone for translating this powerful technology from research laboratories to clinical diagnostics and therapeutic applications. Success in this domain would democratize access to spatial transcriptomics across diverse research contexts and enable previously impossible studies of spatially resolved gene expression in precious biological samples.
The fundamental challenge in spatial transcriptomics lies in balancing spatial resolution with molecular sensitivity, particularly when working with limited sample material. Current platforms face inherent trade-offs between the number of genes detected, spatial resolution, and sample input requirements. This limitation becomes particularly pronounced in clinical applications, rare tissue samples, or precious biological specimens where material availability is constrained.
The primary technical goal is to develop methodologies and protocols that can significantly enhance the detection sensitivity of spatial transcriptomics platforms when applied to small sample sizes. This encompasses improving capture efficiency of mRNA molecules, optimizing library preparation protocols for low-input samples, and developing computational approaches that can extract maximum information from limited data. Enhanced sensitivity would enable detection of lowly expressed genes, rare cell types, and subtle expression gradients that are currently masked by technical noise.
From a biological perspective, the objective extends to enabling comprehensive spatial gene expression profiling of minute tissue sections, single organoids, embryonic samples, or clinical biopsies where tissue availability is limited. This capability would unlock new research opportunities in developmental biology, precision medicine, and rare disease studies where sample scarcity has traditionally limited spatial analysis.
The technological advancement in small sample spatial transcriptomics sensitivity represents a critical milestone for translating this powerful technology from research laboratories to clinical diagnostics and therapeutic applications. Success in this domain would democratize access to spatial transcriptomics across diverse research contexts and enable previously impossible studies of spatially resolved gene expression in precious biological samples.
Market Demand for High-Sensitivity Spatial Transcriptomics Solutions
The spatial transcriptomics market is experiencing unprecedented growth driven by the increasing demand for high-resolution tissue analysis in research and clinical applications. The technology's ability to map gene expression patterns while preserving spatial context has revolutionized fields ranging from cancer research to developmental biology. However, current limitations in sensitivity when working with small sample sizes represent a significant barrier to broader adoption across multiple sectors.
Clinical diagnostics represents one of the most promising market segments for enhanced spatial transcriptomics solutions. Pathology laboratories frequently encounter scenarios where tissue samples are limited, particularly in rare disease cases, pediatric samples, or when dealing with precious archived specimens. The ability to extract meaningful spatial gene expression data from minimal tissue amounts would dramatically expand the diagnostic capabilities of these facilities and enable more precise treatment decisions.
The pharmaceutical industry demonstrates substantial interest in high-sensitivity spatial transcriptomics for drug development applications. During preclinical studies, researchers often work with limited tissue samples from animal models or human organoids. Enhanced sensitivity would enable more comprehensive analysis of drug mechanisms, toxicity patterns, and therapeutic efficacy at the tissue level, potentially accelerating drug discovery timelines and reducing development costs.
Academic research institutions constitute another major market segment driving demand for improved sensitivity solutions. Many research projects involve rare tissue types, historical samples, or experimental conditions that yield limited material. The ability to generate robust spatial transcriptomics data from small samples would unlock new research possibilities and enable studies that are currently technically unfeasible.
The emerging field of personalized medicine creates additional market opportunities for high-sensitivity spatial transcriptomics. As healthcare moves toward individualized treatment approaches, the need to analyze small patient-specific tissue samples becomes increasingly critical. This trend is particularly evident in oncology, where understanding tumor heterogeneity and microenvironment interactions requires detailed spatial analysis of limited biopsy material.
Market growth is further supported by technological convergence trends, where spatial transcriptomics is increasingly integrated with other omics technologies and imaging modalities. This integration amplifies the value proposition of enhanced sensitivity solutions, as researchers seek to maximize information extraction from precious samples across multiple analytical dimensions.
Clinical diagnostics represents one of the most promising market segments for enhanced spatial transcriptomics solutions. Pathology laboratories frequently encounter scenarios where tissue samples are limited, particularly in rare disease cases, pediatric samples, or when dealing with precious archived specimens. The ability to extract meaningful spatial gene expression data from minimal tissue amounts would dramatically expand the diagnostic capabilities of these facilities and enable more precise treatment decisions.
The pharmaceutical industry demonstrates substantial interest in high-sensitivity spatial transcriptomics for drug development applications. During preclinical studies, researchers often work with limited tissue samples from animal models or human organoids. Enhanced sensitivity would enable more comprehensive analysis of drug mechanisms, toxicity patterns, and therapeutic efficacy at the tissue level, potentially accelerating drug discovery timelines and reducing development costs.
Academic research institutions constitute another major market segment driving demand for improved sensitivity solutions. Many research projects involve rare tissue types, historical samples, or experimental conditions that yield limited material. The ability to generate robust spatial transcriptomics data from small samples would unlock new research possibilities and enable studies that are currently technically unfeasible.
The emerging field of personalized medicine creates additional market opportunities for high-sensitivity spatial transcriptomics. As healthcare moves toward individualized treatment approaches, the need to analyze small patient-specific tissue samples becomes increasingly critical. This trend is particularly evident in oncology, where understanding tumor heterogeneity and microenvironment interactions requires detailed spatial analysis of limited biopsy material.
Market growth is further supported by technological convergence trends, where spatial transcriptomics is increasingly integrated with other omics technologies and imaging modalities. This integration amplifies the value proposition of enhanced sensitivity solutions, as researchers seek to maximize information extraction from precious samples across multiple analytical dimensions.
Current Limitations in Small Sample Spatial Transcriptomics Sensitivity
Spatial transcriptomics technologies face significant sensitivity constraints when applied to small sample sizes, primarily due to fundamental limitations in molecular detection efficiency and signal amplification capabilities. Current platforms typically achieve only 10-30% capture efficiency for mRNA molecules, meaning the majority of transcripts present in tissue sections remain undetected. This limitation becomes particularly pronounced in small samples where the absolute number of available transcripts is inherently reduced.
The spatial resolution requirements of these technologies create additional sensitivity challenges. High-resolution platforms like Visium HD and CosMx SMI must balance spatial precision with molecular capture efficiency, often sacrificing sensitivity to maintain fine spatial detail. This trade-off is especially problematic for small samples where researchers cannot afford to lose molecular information for spatial granularity.
Technical noise and background interference represent major obstacles in small sample spatial transcriptomics. The signal-to-noise ratio deteriorates significantly when working with limited tissue amounts, as background fluorescence and non-specific binding events constitute a larger proportion of the total signal. Current denoising algorithms and background subtraction methods are optimized for larger datasets and often fail to adequately address noise issues in small sample contexts.
Library preparation protocols introduce substantial molecular losses that disproportionately affect small samples. Multiple enzymatic steps, including reverse transcription, second-strand synthesis, and PCR amplification, each contribute to efficiency losses. These cumulative losses can result in the complete absence of low-abundance transcripts that might be detectable in larger samples, leading to false negatives and incomplete transcriptional profiles.
Computational analysis pipelines present additional sensitivity limitations. Standard normalization methods and statistical frameworks assume sufficient molecular counts for reliable quantification, assumptions that frequently fail with small samples. Current imputation methods struggle to accurately reconstruct missing expression data when the underlying signal is weak, potentially introducing artifacts that compromise biological interpretation.
Cross-contamination and edge effects pose unique challenges for small samples. The proportion of tissue affected by sectioning artifacts, fixation gradients, and handling damage increases substantially in smaller specimens. These technical artifacts can mask genuine biological signals or introduce spurious spatial patterns that confound downstream analysis.
The spatial resolution requirements of these technologies create additional sensitivity challenges. High-resolution platforms like Visium HD and CosMx SMI must balance spatial precision with molecular capture efficiency, often sacrificing sensitivity to maintain fine spatial detail. This trade-off is especially problematic for small samples where researchers cannot afford to lose molecular information for spatial granularity.
Technical noise and background interference represent major obstacles in small sample spatial transcriptomics. The signal-to-noise ratio deteriorates significantly when working with limited tissue amounts, as background fluorescence and non-specific binding events constitute a larger proportion of the total signal. Current denoising algorithms and background subtraction methods are optimized for larger datasets and often fail to adequately address noise issues in small sample contexts.
Library preparation protocols introduce substantial molecular losses that disproportionately affect small samples. Multiple enzymatic steps, including reverse transcription, second-strand synthesis, and PCR amplification, each contribute to efficiency losses. These cumulative losses can result in the complete absence of low-abundance transcripts that might be detectable in larger samples, leading to false negatives and incomplete transcriptional profiles.
Computational analysis pipelines present additional sensitivity limitations. Standard normalization methods and statistical frameworks assume sufficient molecular counts for reliable quantification, assumptions that frequently fail with small samples. Current imputation methods struggle to accurately reconstruct missing expression data when the underlying signal is weak, potentially introducing artifacts that compromise biological interpretation.
Cross-contamination and edge effects pose unique challenges for small samples. The proportion of tissue affected by sectioning artifacts, fixation gradients, and handling damage increases substantially in smaller specimens. These technical artifacts can mask genuine biological signals or introduce spurious spatial patterns that confound downstream analysis.
Current Approaches for Boosting Small Sample Sensitivity
01 Enhanced detection methods for spatial transcriptomics
Advanced detection techniques and methodologies are employed to improve the sensitivity of spatial transcriptomics analysis. These methods focus on optimizing signal capture and reducing background noise to achieve better detection limits for gene expression mapping in tissue samples. The approaches include improved probe design, enhanced imaging systems, and optimized detection protocols that can identify low-abundance transcripts with greater accuracy.- Enhanced detection methods for spatial transcriptomics: Advanced detection techniques and methodologies are employed to improve the sensitivity of spatial transcriptomics analysis. These methods focus on optimizing signal capture and reducing background noise to achieve better detection limits for gene expression mapping in tissue samples. The approaches include improved probe design, enhanced imaging systems, and optimized detection protocols that can identify low-abundance transcripts with greater accuracy.
- Signal amplification techniques for improved sensitivity: Various signal amplification strategies are implemented to enhance the detection sensitivity in spatial transcriptomics workflows. These techniques involve enzymatic amplification, fluorescence enhancement, and signal boosting methods that allow for the detection of rare transcripts and low-expression genes within specific spatial locations. The amplification approaches help overcome limitations in detecting weak signals while maintaining spatial resolution.
- Computational algorithms for sensitivity optimization: Sophisticated computational methods and algorithms are developed to improve the analytical sensitivity of spatial transcriptomics data processing. These approaches include machine learning models, statistical frameworks, and data processing pipelines that can extract meaningful information from noisy datasets and enhance the detection of subtle expression patterns. The computational tools focus on noise reduction, signal enhancement, and improved data interpretation.
- Sample preparation and processing optimization: Optimized sample preparation protocols and processing methods are crucial for maximizing sensitivity in spatial transcriptomics experiments. These approaches involve tissue handling techniques, fixation methods, permeabilization protocols, and storage conditions that preserve RNA integrity and maintain spatial information. The optimization focuses on minimizing RNA degradation while ensuring efficient probe penetration and binding.
- Integrated platforms and instrumentation advances: Comprehensive integrated platforms and advanced instrumentation systems are designed to enhance overall sensitivity in spatial transcriptomics applications. These systems combine multiple technological components including improved optics, automated workflows, and specialized hardware configurations that work together to achieve higher detection sensitivity. The platforms integrate sample handling, detection, and analysis capabilities in unified systems optimized for sensitive spatial gene expression analysis.
02 Signal amplification technologies
Various signal amplification strategies are implemented to boost the detection sensitivity in spatial transcriptomics workflows. These technologies enhance weak signals from target molecules, enabling the detection of rare transcripts and improving overall assay performance. The amplification methods help overcome limitations associated with low-abundance gene expression while maintaining spatial resolution and specificity.Expand Specific Solutions03 Computational algorithms for sensitivity enhancement
Sophisticated computational methods and algorithms are developed to process and analyze spatial transcriptomics data with improved sensitivity. These approaches utilize advanced statistical models, machine learning techniques, and data processing algorithms to extract meaningful information from noisy datasets and enhance the detection of subtle expression patterns across different spatial regions.Expand Specific Solutions04 Sample preparation and processing optimization
Optimized sample preparation protocols and processing methods are designed to maximize the sensitivity of spatial transcriptomics experiments. These techniques focus on preserving RNA integrity, improving tissue sectioning methods, and enhancing molecular accessibility while maintaining spatial information. The optimization strategies help reduce technical variability and improve reproducibility of sensitive measurements.Expand Specific Solutions05 Integrated platform technologies for high-sensitivity analysis
Comprehensive integrated platforms combine multiple technological components to achieve enhanced sensitivity in spatial transcriptomics applications. These systems integrate hardware improvements, software optimization, and workflow enhancements to provide end-to-end solutions for sensitive spatial gene expression analysis. The platforms are designed to handle complex tissue samples and provide reliable, high-resolution spatial transcriptomic data.Expand Specific Solutions
Key Players in Spatial Transcriptomics Technology Development
The spatial transcriptomics field is experiencing rapid growth with significant market expansion driven by increasing demand for high-resolution tissue analysis. The industry is transitioning from early adoption to mainstream implementation, with market leaders like 10X Genomics and Illumina establishing dominant positions through comprehensive platform offerings. Technology maturity varies significantly across players - established companies such as 10X Genomics, Illumina, and BGI Research have developed robust, commercially viable solutions, while emerging players like Curio Bioscience and Small Machines are introducing innovative approaches. Academic institutions including MIT, Harvard, and The Broad Institute continue driving fundamental research breakthroughs. The competitive landscape shows consolidation trends, evidenced by Takara Bio's recent acquisition of Curio Bioscience, indicating market maturation and the critical importance of addressing sensitivity challenges in small sample applications for broader clinical adoption.
10X Genomics, Inc.
Technical Solution: 10X Genomics has developed the Visium platform for spatial gene expression analysis, which utilizes spatially barcoded oligonucleotides on glass slides to capture mRNA from tissue sections. To boost sensitivity in small sample sizes, they employ optimized reverse transcription protocols and enhanced library preparation methods that maximize transcript capture efficiency. Their CytAssist instrument enables automated sample processing with improved tissue permeabilization and probe hybridization conditions. The company has also introduced high-density capture arrays and advanced computational algorithms for signal amplification and noise reduction, allowing detection of low-abundance transcripts even in limited tissue samples.
Strengths: Market-leading platform with established protocols, comprehensive bioinformatics pipeline, high reproducibility. Weaknesses: High cost per sample, requires specialized equipment, limited to predetermined capture areas.
BGI Research
Technical Solution: BGI Research has developed the Stereo-seq technology platform that achieves subcellular resolution spatial transcriptomics through DNA nanoball arrays. For small sample sensitivity enhancement, they utilize optimized tissue processing protocols including controlled permeabilization and enhanced reverse transcription conditions. Their approach incorporates advanced signal amplification strategies using rolling circle amplification and optimized PCR conditions specifically designed for low-input samples. BGI's computational pipeline includes machine learning algorithms for signal enhancement and background noise reduction, enabling detection of rare transcripts in limited tissue samples through sophisticated statistical modeling and data imputation methods.
Strengths: High spatial resolution, cost-effective sequencing, strong computational capabilities. Weaknesses: Limited global market penetration, newer technology with less validation, requires specialized expertise.
Core Innovations in Sensitivity Enhancement Technologies
Methods and systems for increasing capture potential of a spatial array
PatentPendingUS20250101412A1
Innovation
- The development of an improved capture potential (IC) spatial array, where a template array is projected into a three-dimensional matrix substrate, increasing the number of capture probes per area and enhancing the capture potential by distributing probes throughout a volume.
Method for spatial tagging and analysing nucleic acids in a biological specimen
PatentPendingEP4650458A2
Innovation
- A method combining the release and extension of capture probes from a solid substrate simultaneously, using a cleavage enzyme with a polymerase enzyme in a reaction mixture, allowing nucleic acids to hybridize and extend as templates for enhanced capture and tagging.
Sample Preparation Optimization Strategies
Sample preparation represents the most critical upstream factor determining the success of spatial transcriptomics experiments, particularly when working with limited tissue quantities. The quality and integrity of RNA preservation directly correlate with detection sensitivity, making optimization of sample handling protocols essential for maximizing transcriptomic signal recovery from small specimens.
Tissue fixation methods significantly impact RNA quality and subsequent detection capabilities. Fresh frozen samples typically yield superior RNA integrity compared to formalin-fixed paraffin-embedded tissues, though recent advances in crosslinking-reversible fixatives have improved FFPE sample performance. For small samples, rapid freezing protocols using liquid nitrogen or dry ice minimize RNA degradation during the critical initial preservation phase. Alternative fixation approaches, such as glyoxal-based fixatives or alcohol-based solutions, offer improved RNA preservation while maintaining tissue morphology essential for spatial context.
Sectioning parameters require careful optimization to balance tissue integrity with RNA preservation. Thinner sections, typically 10-20 micrometers, provide better spatial resolution but may compromise RNA yield from small samples. Cryosectioning at optimal temperatures between -15°C to -20°C prevents tissue damage while maintaining RNA stability. The use of RNase-free environments and tools throughout the sectioning process becomes particularly crucial when working with limited material where contamination or degradation cannot be compensated by larger sample sizes.
Permeabilization strategies must be tailored to specific tissue types and sample dimensions. Enzymatic permeabilization using pepsin or proteinase K requires precise timing and concentration adjustments for small samples to avoid over-digestion while ensuring adequate RNA accessibility. Temperature and incubation duration optimization becomes critical, as small samples may require reduced treatment times to prevent tissue loss while maintaining sufficient permeabilization for probe penetration.
Storage conditions between preparation steps significantly influence final sensitivity outcomes. Maintaining samples at appropriate temperatures with desiccants and inert atmospheres prevents RNA degradation during processing delays. The implementation of quality control checkpoints throughout preparation workflows enables early detection of issues that could compromise downstream sensitivity, allowing for protocol adjustments before proceeding to expensive sequencing steps.
Tissue fixation methods significantly impact RNA quality and subsequent detection capabilities. Fresh frozen samples typically yield superior RNA integrity compared to formalin-fixed paraffin-embedded tissues, though recent advances in crosslinking-reversible fixatives have improved FFPE sample performance. For small samples, rapid freezing protocols using liquid nitrogen or dry ice minimize RNA degradation during the critical initial preservation phase. Alternative fixation approaches, such as glyoxal-based fixatives or alcohol-based solutions, offer improved RNA preservation while maintaining tissue morphology essential for spatial context.
Sectioning parameters require careful optimization to balance tissue integrity with RNA preservation. Thinner sections, typically 10-20 micrometers, provide better spatial resolution but may compromise RNA yield from small samples. Cryosectioning at optimal temperatures between -15°C to -20°C prevents tissue damage while maintaining RNA stability. The use of RNase-free environments and tools throughout the sectioning process becomes particularly crucial when working with limited material where contamination or degradation cannot be compensated by larger sample sizes.
Permeabilization strategies must be tailored to specific tissue types and sample dimensions. Enzymatic permeabilization using pepsin or proteinase K requires precise timing and concentration adjustments for small samples to avoid over-digestion while ensuring adequate RNA accessibility. Temperature and incubation duration optimization becomes critical, as small samples may require reduced treatment times to prevent tissue loss while maintaining sufficient permeabilization for probe penetration.
Storage conditions between preparation steps significantly influence final sensitivity outcomes. Maintaining samples at appropriate temperatures with desiccants and inert atmospheres prevents RNA degradation during processing delays. The implementation of quality control checkpoints throughout preparation workflows enables early detection of issues that could compromise downstream sensitivity, allowing for protocol adjustments before proceeding to expensive sequencing steps.
Computational Methods for Signal Amplification
Computational methods for signal amplification represent a critical frontier in addressing the inherent limitations of spatial transcriptomics when working with small sample sizes. These approaches leverage sophisticated algorithms to extract maximum information from limited data while maintaining spatial resolution and biological relevance. The fundamental challenge lies in distinguishing true biological signals from technical noise, particularly when transcript counts are sparse across spatial coordinates.
Machine learning-based denoising algorithms have emerged as powerful tools for signal enhancement in spatial transcriptomics datasets. Deep learning architectures, including variational autoencoders and graph neural networks, can learn complex patterns in spatial gene expression data to impute missing values and reduce noise. These methods exploit both the spatial relationships between neighboring spots and the co-expression patterns among genes to reconstruct more complete expression profiles from sparse measurements.
Statistical modeling approaches offer another avenue for computational signal amplification. Bayesian frameworks can incorporate prior knowledge about gene expression patterns and spatial dependencies to improve signal detection sensitivity. Zero-inflated negative binomial models and other specialized distributions designed for count data help distinguish between true biological zeros and technical dropouts, enabling more accurate quantification of low-abundance transcripts.
Spatial smoothing and interpolation techniques provide direct methods for signal enhancement by leveraging the spatial continuity assumption in biological tissues. Gaussian kernel smoothing, kriging, and other spatial statistics methods can amplify weak signals by borrowing information from neighboring locations. Advanced approaches combine multiple smoothing scales or use adaptive kernels that adjust to local tissue architecture and expression heterogeneity.
Integration strategies that combine multiple computational approaches show particular promise for maximizing sensitivity gains. Ensemble methods that merge predictions from different algorithms can achieve more robust signal amplification than individual techniques. Multi-modal integration frameworks that incorporate histological images or other complementary data types can provide additional context for computational signal enhancement, leading to more accurate and biologically meaningful results in small sample studies.
Machine learning-based denoising algorithms have emerged as powerful tools for signal enhancement in spatial transcriptomics datasets. Deep learning architectures, including variational autoencoders and graph neural networks, can learn complex patterns in spatial gene expression data to impute missing values and reduce noise. These methods exploit both the spatial relationships between neighboring spots and the co-expression patterns among genes to reconstruct more complete expression profiles from sparse measurements.
Statistical modeling approaches offer another avenue for computational signal amplification. Bayesian frameworks can incorporate prior knowledge about gene expression patterns and spatial dependencies to improve signal detection sensitivity. Zero-inflated negative binomial models and other specialized distributions designed for count data help distinguish between true biological zeros and technical dropouts, enabling more accurate quantification of low-abundance transcripts.
Spatial smoothing and interpolation techniques provide direct methods for signal enhancement by leveraging the spatial continuity assumption in biological tissues. Gaussian kernel smoothing, kriging, and other spatial statistics methods can amplify weak signals by borrowing information from neighboring locations. Advanced approaches combine multiple smoothing scales or use adaptive kernels that adjust to local tissue architecture and expression heterogeneity.
Integration strategies that combine multiple computational approaches show particular promise for maximizing sensitivity gains. Ensemble methods that merge predictions from different algorithms can achieve more robust signal amplification than individual techniques. Multi-modal integration frameworks that incorporate histological images or other complementary data types can provide additional context for computational signal enhancement, leading to more accurate and biologically meaningful results in small sample studies.
Unlock deeper insights with PatSnap Eureka Quick Research — get a full tech report to explore trends and direct your research. Try now!
Generate Your Research Report Instantly with AI Agent
Supercharge your innovation with PatSnap Eureka AI Agent Platform!